aTYR PHARMA INC

Biotechnology company · San Diego, California, United States · Nasdaq: ATYR

aTYR PHARMA INC is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker ATYR. It has reported private securities offerings to the US SEC, most recently $46 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

aTYR PHARMA at a glance

Typebiotechnology company

HeadquartersSan Diego, California, United States

Stock listingNasdaq: ATYR

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1339970

What does aTYR PHARMA do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $45.8 million sold (2017).

Frequently asked questions about aTYR PHARMA

Where is aTYR PHARMA headquartered?

aTYR PHARMA INC is headquartered in San Diego, California, United States.

What does aTYR PHARMA do?

aTYR PHARMA INC is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is aTYR PHARMA a public company?

Yes. aTYR PHARMA INC trades on Nasdaq under the ticker ATYR.

Similar companies

Biolinq IncSan Diego, California, United States
BioAtla, Inc.San Diego, California, United States
Neurocrine Biosciences IncSan Diego, California, United States
ImmunityBio, Inc.San Diego, California, United States
Sorrento Therapeutics, Inc.San Diego, California, United States
Protego Biopharma, Inc.San Diego, California, United States
Tempo Therapeutics, Inc.San Diego, California, United States
Fate Therapeutics IncSan Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.